Title
|
Company Name
|
Platform / Modality
|
Target
|
Investor/Partner Relations
|
Aminoflavone Prodrug (AFP464) - A Novel Approach to Cancer |
Tigris Pharmaceutical, Inc. |
Small Molecules |
Treatment of MCF-7 human breast cancer cells with AF resulted in translocation of arylhydrocarbon receptor (AhR; a transcriptional regulator of CYP1A1) from the cytoplasm to the nucleus and subsequent interaction with xenobiotic-responsive element (XRE) sequence on the CYP1A1 promoter region to form AhR-XRE protein DNA complexes |
Licensing |
Autologous Bone Marrow Adult Stem Therapy (ABMAS) |
BioArray Technologies, Inc. |
Biologic |
Damaged Heart Muscle Tissue after Heart Attack |
VC, Licensing, Strategic Partner |
Drug Screening System Based on Engineered Tissue Constructs and Measurement of Mechanical Properties of Tissues |
Invivo Sciences LLC |
Biologic |
|
VC, Licensing, Manufacturing, Strategic Partner |
Fast Drug Sreening, High Throughput Profiling of Plant Extracts Using Engineered Heart Tissues |
INVIVOSCIENCES LLC |
Biologic |
|
VC, Licensing, Manufacturing, Strategic Partner |
Micronucleus Assessments using Flow Cytometry and a few Drops of Blood through the Species (mouse, rat, dog, non-human primate, human) |
Litron Laboratories |
Imaging |
Chromosome breaks (long understood to be precursors of cancer) are measured using MicroFlow® technology (requires only a few drops of blood). Specifically, micronuclei are measured indicating chromosome breaks. |
Licensing, Strategic Partner |
PancAtak™ |
Advantagene, Inc. |
Biologic |
Patient-specific vaccine from non-patient-specific product |
Strategic Partner |
TriGrid Delivery System |
Ichor Medical Systems |
Other (Nucleic Acid Delivery) |
|
Licensing, Strategic Partner |